Israel’s role in new anti-psychotic medications

Prof. Jonathan Rabinowitz, of Bar-Ilan University is the academic head of the NewMeds group on advanced data analysis techniques. He is working in a EU-funded consortium to find new methods for developing treatments for depression and schizophrenia.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *